See more : Belships ASA (NS6.BE) Income Statement Analysis – Financial Results
Complete financial analysis of Saintmed Public Company Limited (SMD.BK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Saintmed Public Company Limited, a leading company in the Medical – Distribution industry within the Healthcare sector.
- PT Japfa Comfeed Indonesia Tbk (JPFA.JK) Income Statement Analysis – Financial Results
- Javelin Minerals Limited (JAV.AX) Income Statement Analysis – Financial Results
- Grand Hall Enterprise Co., Ltd. (8941.TWO) Income Statement Analysis – Financial Results
- WCM Beteiligungs- und Grundbesitz-AG (0QGK.L) Income Statement Analysis – Financial Results
- Zhejiang Garden Bio-chemical High-tech Co., Ltd. (300401.SZ) Income Statement Analysis – Financial Results
Saintmed Public Company Limited (SMD.BK)
About Saintmed Public Company Limited
SaintMed Public Company Limited imports and distributes medical equipment to private hospitals, clinics, and the general public in Thailand. The company also offers medical, sleep test, and other related services. In addition, it rents medical equipment. The company was founded in 1998 and is based in Bang Bua Thong, Thailand.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 827.35M | 2.01B | 1.62B | 660.94M | 618.63M | 506.03M | 468.73M | 564.74M |
Cost of Revenue | 530.24M | 1.42B | 990.09M | 383.92M | 361.80M | 312.71M | 290.32M | 347.59M |
Gross Profit | 297.11M | 591.83M | 631.02M | 277.02M | 256.83M | 193.31M | 178.41M | 217.14M |
Gross Profit Ratio | 35.91% | 29.45% | 38.93% | 41.91% | 41.52% | 38.20% | 38.06% | 38.45% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 89.89M | 89.14M | 90.86M | 73.91M | 71.19M | 60.66M | 64.20M | 78.63M |
Selling & Marketing | 117.20M | 128.85M | 126.40M | 97.77M | 100.85M | 77.56M | 72.44M | 56.01M |
SG&A | 207.10M | 217.99M | 217.26M | 171.68M | 172.04M | 138.22M | 118.14M | 134.64M |
Other Expenses | 0.00 | 4.19M | 1.62M | 254.12K | 355.98K | 0.00 | 0.00 | 0.00 |
Operating Expenses | 207.10M | 217.99M | 217.26M | 171.68M | 172.04M | 138.22M | 118.14M | 132.74M |
Cost & Expenses | 737.33M | 1.64B | 1.21B | 555.60M | 533.84M | 450.93M | 408.46M | 480.33M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 16.87M | 15.83M | 15.43M |
Interest Expense | 3.34M | 8.55M | 11.14M | 9.31M | 15.66M | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 30.86M | 31.34M | 28.70M | 27.06M | 26.72M | 21.48M | 18.49M | 9.51M |
EBITDA | 127.79M | 406.20M | 435.40M | 133.10M | 112.08M | 76.57M | 84.28M | 92.01M |
EBITDA Ratio | 15.45% | 20.37% | 27.38% | 20.14% | 18.12% | 15.13% | 16.80% | 16.29% |
Operating Income | 90.01M | 378.03M | 415.37M | 105.59M | 85.15M | 55.09M | 60.27M | 82.50M |
Operating Income Ratio | 10.88% | 18.81% | 25.62% | 15.98% | 13.76% | 10.89% | 12.86% | 14.61% |
Total Other Income/Expenses | 3.58M | -7.53M | -18.02M | -8.84M | -8.72M | -16.43M | -10.30M | -13.54M |
Income Before Tax | 93.59M | 366.31M | 395.73M | 96.50M | 76.07M | 38.67M | 49.96M | 68.97M |
Income Before Tax Ratio | 11.31% | 18.23% | 24.41% | 14.60% | 12.30% | 7.64% | 10.66% | 12.21% |
Income Tax Expense | 14.35M | 69.65M | 75.89M | 18.76M | 15.64M | 8.15M | 10.58M | 14.43M |
Net Income | 79.24M | 296.66M | 319.68M | 77.75M | 60.44M | 30.52M | 39.39M | 54.54M |
Net Income Ratio | 9.58% | 14.76% | 19.72% | 11.76% | 9.77% | 6.03% | 8.40% | 9.66% |
EPS | 0.35 | 1.32 | 1.53 | 0.35 | 0.27 | 0.14 | 0.18 | 0.32 |
EPS Diluted | 0.35 | 1.32 | 1.53 | 0.35 | 0.27 | 0.14 | 0.18 | 0.32 |
Weighted Avg Shares Out | 223.91M | 224.68M | 208.52M | 224.70M | 224.70M | 224.70M | 224.70M | 168.00M |
Weighted Avg Shares Out (Dil) | 223.91M | 224.68M | 208.52M | 224.70M | 224.70M | 224.70M | 224.70M | 168.00M |
Source: https://incomestatements.info
Category: Stock Reports